"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
Articles tagged with: Purnells
Three New Trustees Appointed
15th May 2014
Deloitte | Pinsent Masons | Purnells
Birmingham-based blood cancer charity Cure Leukaemia has announced a record-breaking 42% increase in their annual fundraising for the year ended October 31st 2013. The charity raised £863,474 last year, a figure that is worth over £8 million in potentially life saving...
PREV
1
NEXT